Attribute

Rotarix

Rotateq

Manufacturer

GlaxoSmithKline

Merck

No. of doses per fully immunized child

2

3

No. of doses per vial

1

1

Vaccine Vial Monitor Type

On cap

None

Upper age limit (per manufacturers guide)

24 weeks

32 weeks

Efficacy in African trials

72.2% (South Africa)

49.2% (Malawi)

63.9% (Kenya)

55.5% (Ghana)

17.6% (Mali)

Rotavirus strains covered

G1, G3, G4, G9

G1, G2, G3, G4, P1

Min. storage volume per dose (cm3)

17.1

45.9

Minimun storage volume per fully immunized child (cm3)

34.2

137.7

Largest pack size

50

25